- Home
- FDMT vs ZYXI Comparison
FDMT vs ZYXI Comparison
Compare FDMT & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- ZYXI
- Stock Information
- Founded
- FDMT 2013
- ZYXI 1996
- Country
- FDMT United States
- ZYXI United States
- Employees
- FDMT N/A
- ZYXI N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FDMT Health Care
- ZYXI Health Care
- Exchange
- FDMT Nasdaq
- ZYXI Nasdaq
- Market Cap
- FDMT 268.6M
- ZYXI 261.5M
- IPO Year
- FDMT 2020
- ZYXI N/A
- Fundamental
- Price
- FDMT $4.64
- ZYXI $7.19
- Analyst Decision
- FDMT Buy
- ZYXI Strong Buy
- Analyst Count
- FDMT 10
- ZYXI 2
- Target Price
- FDMT $36.33
- ZYXI $14.00
- AVG Volume (30 Days)
- FDMT 957.1K
- ZYXI 76.5K
- Earning Date
- FDMT 03-03-2025
- ZYXI 03-07-2025
- Dividend Yield
- FDMT N/A
- ZYXI N/A
- EPS Growth
- FDMT N/A
- ZYXI N/A
- EPS
- FDMT N/A
- ZYXI 0.15
- Revenue
- FDMT $17,000.00
- ZYXI $193,665,000.00
- Revenue This Year
- FDMT N/A
- ZYXI $10.70
- Revenue Next Year
- FDMT $159.36
- ZYXI $19.78
- P/E Ratio
- FDMT N/A
- ZYXI $48.68
- Revenue Growth
- FDMT N/A
- ZYXI 4.21
- 52 Week Low
- FDMT $4.41
- ZYXI $7.12
- 52 Week High
- FDMT $36.25
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- FDMT 40.01
- ZYXI 34.08
- Support Level
- FDMT $4.41
- ZYXI $7.27
- Resistance Level
- FDMT $5.42
- ZYXI $7.70
- Average True Range (ATR)
- FDMT 0.48
- ZYXI 0.28
- MACD
- FDMT -0.05
- ZYXI -0.04
- Stochastic Oscillator
- FDMT 9.38
- ZYXI 6.93
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.